Responses seen with avelumab in trials in mesothelioma, gastric/gastroesophageal junction cancer Oct. 21, 2015
Alnylam describes a more potent RNAi agent targeting transthyretin for treating amyloidosis Oct. 20, 2015
Radiolabeled G-02113 may be useful for in vivo imaging of sst receptor-expressing tumors Oct. 20, 2015